This test is most useful if any of these apply to you.
An unexplained fever after possible tick exposure can raise suspicion for babesiosis, especially when it comes with anemia or low platelets. Babesia microti IgG screening looks for your immune response to the parasite. A positive result supports past or current infection, but it cannot establish that the parasite is causing your symptoms now.
Babesia microti is a single-celled parasite transmitted mainly by infected blacklegged ticks in the United States. Mice and other small mammals help maintain its cycle in nature. Inside your body, it multiplies in red blood cells and contributes to their destruction. Infection can also spread through contaminated blood transfusions and, rarely, from mother to baby.
IgG is a class of antibody that can remain after an infection has resolved. This established antibody test uses serum from a blood draw. Serum is the liquid left after blood clots. An indirect immunofluorescence assay, or IFA, detects whether your IgG binds to material from B. microti.
The screen reports detected or not detected. A positive screen can lead to a separate antibody titer. A titer describes how far the sample can be diluted while antibody binding remains detectable. The screening result itself has no numerical antibody level, and neither result counts parasites in your blood.
Some infections cause no symptoms. Others cause fever, chills, sweats, fatigue, headache, or body aches. Red blood cell destruction can cause anemia, jaundice, and dark urine. Low platelets and raised liver enzymes are common laboratory findings during symptomatic illness, though these findings also occur in other diseases.
Older adults, people without a functioning spleen, and people with weakened immune systems have a greater risk of severe illness. Persistent or relapsing infection is a particular concern with B-cell cancers and treatments such as rituximab. B cells help produce antibodies, so disrupting them can impair the response to the parasite. Severe disease can also occur outside these groups.
Babesiosis can sometimes trigger autoimmune hemolytic anemia. This happens when the immune system attacks your own red blood cells. In one case series, six people without spleens developed the warm-antibody form two to four weeks after their babesiosis diagnosis, despite treatment and clearance of parasites from blood smears. A cold-antibody form has also been reported. These antibodies against red blood cells are different from the antibodies against B. microti detected by this screen.
The same blacklegged ticks can transmit Lyme disease, babesiosis, and anaplasmosis. Having one infection therefore raises the possibility of another, but antibodies to several organisms do not establish that several infections are active. Persistent fever or unexplained blood count abnormalities during a Lyme illness make coinfection more relevant than fatigue alone.
Antibody surveys find evidence of exposure in people who never recognized an illness. An older study in eastern Switzerland found B. microti IgG in 1.5% of the residents tested. That figure describes one place and study population; it isn't an estimate of your risk after a tick bite.
A study in Sweden and the Åland Islands followed 53 people bitten by Babesia-positive ticks, along with a comparison group. No participant developed newly detectable B. microti IgG during follow-up, and no one in the exposed group reported symptoms suggestive of babesiosis. The ticks carried several Babesia species while the antibody test targeted B. microti, which limits conclusions about infection by other species.
An infected blood donor can feel well and still transmit the parasite. A research program screened 89,153 donations using a different antibody assay together with DNA testing and identified potentially infectious donations. That study supports blood donation screening; it does not establish the performance of this IgG screen alone. US blood centers use dedicated tests for parasite genetic material in regions covered by FDA screening recommendations.
Parasites can be detectable before antibodies appear. The timing varies, so there is no dependable day after a bite when a negative IgG screen rules out infection. Human blood donor studies have documented samples that were positive for parasite DNA while antibody tests were still negative.
Antibodies can persist for a year or more after apparent clearance of infection. In an older follow-up study of 16 people, serum antibody titers rose during the first weeks of illness and then fell gradually over five to six months. Those were titer measurements, not numerical results from a qualitative screen. A falling titer or a persistently positive screen cannot, by itself, establish whether treatment succeeded.
An older four-laboratory study of serum IFA testing detected most established babesiosis cases, with sensitivity ranging from 88% to 96%. Specificity ranged from 90% to 100%. These estimates came from a small validation study and do not describe the reliability of testing before an antibody response develops.
Research assays are exploring earlier detection. In a 2025 study, an experimental bead-based IgG assay detected antibodies in six of 13 human samples that were PCR-positive but negative by IFA. That result belongs to the experimental assay. It does not mean this screen has the same ability to detect early infection.
A change from not detected to detected can support an antibody response developing over time. Repeated positive screens provide no information about whether the amount of antibody has risen or fallen. Paired titers can provide additional evidence about a recent infection, but antibody results alone are a poor measure of recovery.
Evidence-backed interventions that affect your Babesia Microti Antibody IgG Screen level
Babesia Microti Antibody IgG Screen is best interpreted alongside these tests.
Babesia Microti Antibody IgG Screen is included in these pre-built panels.
See whether your body has met the blood parasite behind babesiosis, and whether that encounter looks recent or long past.